Medical Training AIExosome Therapy Fundamentals
You'll be able to explain exosome biology, evaluate product characteristics, and reason through clinical use cases with a defensible framework.
What this track covers
This track covers extracellular vesicle biology and how exosome-based products differ from cell-based regenerative approaches in composition, handling, and mechanism. It's built for clinicians who need to evaluate emerging regenerative products and discuss them accurately with patients and colleagues.
What you will practice
- Distinguish exosome-based products from stem cell or PRP-based approaches by mechanism
- Identify what cargo (growth factors, cytokines, RNA species, proteins) a product claims to deliver and why that matters
- Evaluate product sourcing, processing, and storage claims for consistency and plausibility
- Recognize gaps between marketed claims and current evidence for a given indication
- Frame patient conversations about risks, unknowns, and realistic expectations
Simulator scenario
A patient who read about exosome therapy online asks a clinician to explain how it works and whether it's appropriate for their condition, requiring the clinician to separate mechanism from marketing claims.
Board question topics
- Extracellular vesicle biology and cargo composition
- Differences between cell-based and cell-free regenerative approaches
- Product handling and storage considerations
- Evidence gaps and regulatory considerations for emerging regenerative products
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free